The present invention provides methods of synthesizing D-α-methyldopa and L-α-methyldopa.

The present invention provides methods of synthesizing D-α-methyldopa and L-α-methyldopa.

The present invention provides methods of synthesizing D-α-methyldopa and L-α-methyldopa.

Coating compositions and methods providing a high build, fast drying, fast hardening non-amine containing aqueous latex binders are provided, wherein the coating composition is applied to a substrate at a wet film thickness to about 15 mils that ensure drying times of less than 10 minutes. The binder requires the use of at least one specific coalescent solvent with both anionic and non-anionic surfactants.

Coating compositions and methods providing a high build, fast drying, fast hardening non-amine containing aqueous latex binders are provided, wherein the coating composition is applied to a substrate at a wet film thickness to about 15 mils that ensure drying times of less than 10 minutes. The binder requires the use of at least one specific coalescent solvent with both anionic and non-anionic surfactants.

Various embodiments of the present invention are directed to switchable carboxybetaine-based polymers, hydrogels, and/or elastomers, along with novel related monomers, crosslinkers, and methods. Under acidic conditions, the materials undergo self-cyclization and can catch and kill bacteria. Under neutral/basic conditions, these materials undergo ring-opening and can release killed bacterial cells and resist protein adsorption and bacterial attachment. These smart polymers, hydrogels and elastomers also show excellent mechanical properties making them highly desirable for many biomedical applications.

Various embodiments of the present invention are directed to switchable carboxybetaine-based polymers, hydrogels, and/or elastomers, along with novel related monomers, crosslinkers, and methods. Under acidic conditions, the materials undergo self-cyclization and can catch and kill bacteria. Under neutral/basic conditions, these materials undergo ring-opening and can release killed bacterial cells and resist protein adsorption and bacterial attachment. These smart polymers, hydrogels and elastomers also show excellent mechanical properties making them highly desirable for many biomedical applications.

Provided herein are methods of making the compound of Formula I: ##STR00001##
and certain intermediates involved in such process.

Provided herein are methods of making the compound of Formula I: ##STR00001##
and certain intermediates involved in such process.

The present invention relates to novel Ruthenium complexes of formulae A1-A4 and their use, inter alia, for (1) dehydrogenative coupling of alcohols to esters; (2) hydrogenation of esters to alcohols (including hydrogenation of cyclic esters (lactones) or cyclic di-esters (di-lactones), or polyesters); (3) preparing amides from alcohols and amines—(including the preparation of polyamides (e.g., polypeptides) by reacting dialcohols and diamines and/or polymerization of amino alcohols and/or forming cyclic dipeptides from p-aminoalcohols; (4) hydrogenation of amides (including cyclic dipeptides, polypeptides and polyamides) to alcohols and amines; (5) hydrogenation of organic carbonates (including polycarbonates) to alcohols or hydrogenation of carbamates (including polycarbamates) or urea derivatives to alcohols and amines; (6) dehydrogenation of secondary alcohols to ketones; (7) amidation of esters (i.e., synthesis of amides from esters and amines); (8) acylation of alcohols using esters; (9) coupling of alcohols with water and a base to form carboxylic acids; and (10) preparation of amino acids or their salts by coupling of amino alcohols with water and a base. The present, invention further relates to the use of certain known Ruthenium complexes for the preparation of amino acids or their salts from amino alcohols.